Research & Innovation
Publications

Treatment of HCC with Lenvatinib or Regorafenib in combination with Cdk5 inhibition – a new promising therapeutic approach to improve the situation of HCC patients

#2021

PMU Author
Petra Huber-Cantonati

All Authors
Petra Huber-Cantonati, L. Kraus, M. A. Ardelt, J. Pachmayr

Abstract

We are sorry. The full text is not available.

Latest Publication

#2025

#Abstract

Valentin Fischill-Neudeck, Antje van der Zee-Neuen, Margitta B. Beil-Hildebrand Strengthening Professional Health Literacy: A Theory-Based Approach to Empower Nursing Practice

#2025

#Original Article

Margaux Delporte, Johan Verbeeck, Isabella Brambilla, Georg Zimmermann, Geert Molenberghs, Rima Nabbout, Dravet syndrome, REGISTRY; RARE DISEASES; DRAVET SYNDROME; Natural history;

#2025

#Editorial

Eunkyeong Oh, Alberto Lucchini, Peter Nydahl Personalized approaches to ICU Distress

Back to Overview

Paracelsus Medical University (PMU) Research & Innovation Publications

Treatment of HCC with Lenvatinib or Regorafenib in...